SCHEMBL7470942

SCHEMBL7470942

COc1nc2cc(C)c(C)c(N)c2nc1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NQO2 P16083 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 4/20 0.34
RECQL P46063 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
LMNA P02545 3/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 3/20 0.33
POLB P06746 2/20 0.33
THRB P10828 2/20 0.33
MAPK1 P28482 2/20 0.33
G6PD P11413 1/20 0.33
PKM P14618 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GAA P10253 1/20 0.33
BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27513854 0.83 PDPK1 (0.36) L3MBTL1MAPTNPC1RAB9AKDM4E
SCHEMBL27535088 0.83 L3MBTL1 (0.35) L3MBTL1MEN1KMT2ANQO2SMN1; SMN2
SCHEMBL7473830 0.83 NQO2 (0.34) L3MBTL1MEN1KMT2ANQO2SMN1; SMN2
SCHEMBL7472768 0.83 HRH4 (0.37) L3MBTL1MEN1KMT2ANQO2MAPT
Hydrochloric Acid SCHEMBL27440727 0.81 L3MBTL1 (0.34) L3MBTL1MEN1KMT2ANQO2SMN1; SMN2
SCHEMBL27395257 0.77 MAPT (0.38) MEN1KMT2ASMN1; SMN2MAPTRECQL
SCHEMBL7811964 0.75 NQO2 (0.33) NQO2MAPTRECQLNPC1RAB9A
SCHEMBL7810829 0.75 NQO2 (0.33) NQO2MAPTRECQLNPC1RAB9A
SCHEMBL7470290 0.74 SMN1; SMN2 (0.37) L3MBTL1MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL27459361 0.74 NQO2 (0.48) MEN1KMT2ANQO2SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5863917-A ANXIOLYTIC AGENT, ANTICONVULSANTS, ANALGESICS AND NEUROPROTECTIVES. PFIZER, INC. (US) 1999-01-26 US disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
WO-1997031902-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-04 WO disclosed
EP-0792874-A1 Quinoxaline derivatives useful in therapy Pfizer Limited (GB) 1997-09-03 EP disclosed
CN-1158610-A Quinoxaline derivatives useful in therapy PFIZER LTD (IE) 1997-09-03 CN disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed